VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,386,000 | -61.5% | 62,825 | -32.4% | 0.92% | -58.4% |
| Q3 2015 | $16,575,000 | -21.7% | 92,920 | -2.5% | 2.22% | -9.9% |
| Q2 2015 | $21,169,000 | +32467.7% | 95,290 | +29220.0% | 2.47% | +35185.7% |
| Q1 2015 | $65,000 | -99.6% | 325 | -99.7% | 0.01% | -99.7% |
| Q4 2014 | $17,569,000 | +53139.4% | 122,768 | +49403.2% | 2.06% | +51450.0% |
| Q3 2014 | $33,000 | -99.3% | 248 | -99.4% | 0.00% | -99.5% |
| Q2 2014 | $5,034,000 | +27.6% | 39,918 | +33.4% | 0.82% | -8.1% |
| Q1 2014 | $3,944,000 | +20.4% | 29,918 | +7.3% | 0.89% | -15.4% |
| Q4 2013 | $3,275,000 | +146.4% | 27,895 | +119.0% | 1.06% | +45.1% |
| Q3 2013 | $1,329,000 | – | 12,736 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |